Yakob Liawatidewi - 04 Mar 2024 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
EVP CORP ADMIN CENTER, Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
04 Mar 2024
Net transactions value
$0
Form type
4
Filing time
06 Mar 2024, 17:54:00 UTC
Previous filing
29 Aug 2023
Next filing
08 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Award $0 +10,754 +15% $0.000000 80,423 04 Mar 2024 Direct F1
holding AMPH Common Stock 2,459 04 Mar 2024 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Award $0 +22,655 $0.000000 22,655 04 Mar 2024 Common Stock 22,655 $46.68 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 4, 2025.
F2 The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
F3 The shares subject to the option vest in four equal annual installments beginning on March 4, 2025.